FDA announces opportunity for drug manuf
The USFDA announced next phase of the Quality Management Maturity (QMM) Program for drug manufacturers.
Warning letters, 483s, Recalls, Import Alerts, Audit observations
The USFDA announced next phase of the Quality Management Maturity (QMM) Program for drug manufacturers.